HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $5,330,000 | -7.4% | 48,011 | -1.0% | 1.77% | -19.2% |
Q4 2020 | $5,759,000 | +34.7% | 48,499 | -1.0% | 2.19% | +7.1% |
Q3 2020 | $4,276,000 | +17.7% | 49,004 | +20.8% | 2.04% | +22.6% |
Q2 2020 | $3,632,000 | -21.8% | 40,559 | -12.9% | 1.67% | -25.9% |
Q1 2020 | $4,643,000 | -0.3% | 46,590 | +14.9% | 2.25% | +17.3% |
Q4 2019 | $4,658,000 | -8.9% | 40,541 | 0.0% | 1.92% | -13.0% |
Q3 2019 | $5,114,000 | +33.8% | 40,541 | +27.6% | 2.20% | +4.7% |
Q2 2019 | $3,823,000 | +38.3% | 31,765 | +0.5% | 2.10% | +30.8% |
Q1 2019 | $2,765,000 | -13.4% | 31,609 | -0.9% | 1.61% | -22.6% |
Q4 2018 | $3,192,000 | -2.1% | 31,902 | +12.1% | 2.08% | +2.7% |
Q3 2018 | $3,260,000 | +22.6% | 28,450 | -4.1% | 2.02% | +20.5% |
Q2 2018 | $2,660,000 | +18.6% | 29,657 | -3.2% | 1.68% | +11.4% |
Q1 2018 | $2,242,000 | +33.5% | 30,644 | +6.0% | 1.51% | +23.8% |
Q4 2017 | $1,679,000 | +29.5% | 28,900 | 0.0% | 1.22% | +25.7% |
Q3 2017 | $1,297,000 | +23.5% | 28,900 | +8.7% | 0.97% | +10.5% |
Q2 2017 | $1,050,000 | – | 26,587 | – | 0.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |